Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from Ridgetech ( (RDGT) ).
Ridgetech, Inc., a wholesale distributor of pharmaceutical and healthcare products in China listed on Nasdaq under the ticker RDGT, announced on April 3, 2026 that it will execute a 1-for-150 reverse share split of its ordinary shares. The move will reduce the number of outstanding ordinary shares from 134,835,960 to approximately 898,906 as of April 7, 2026, with no change to shareholders’ proportional ownership other than minor adjustments from rounding up fractional shares.
The reverse split, which was approved by Ridgetech’s board and shareholders, is scheduled to take effect on April 7, 2026 at 5:00 p.m. Eastern Time, after which trading will continue on the Nasdaq Capital Market on a split-adjusted basis under the existing symbol RDGT. By consolidating its share count and increasing the per-share price, the company aims to strengthen its capital markets profile and maintain compliance with Nasdaq listing standards, a step that could be significant for investor perception and market liquidity.
The most recent analyst rating on (RDGT) stock is a Hold with a $0.02 price target. To see the full list of analyst forecasts on Ridgetech stock, see the RDGT Stock Forecast page.
Spark’s Take on RDGT Stock
According to Spark, TipRanks’ AI Analyst, RDGT is a Underperform.
The score is held down primarily by weak financial performance (ongoing operating losses, revenue decline, and still-elevated leverage despite some 2025 improvement) and bearish technical momentum (negative MACD with low RSI). Valuation provides limited support due to a negative P/E and no dividend yield data.
To see Spark’s full report on RDGT stock, click here.
More about Ridgetech
Ridgetech, Inc. is a Cayman Islands–incorporated wholesale distributor of pharmaceutical and other healthcare products in China. The company operates both online and offline, trading on major national e-commerce distribution platforms as well as its own proprietary platform to broaden nationwide reach for drug and healthcare product distribution.
Average Trading Volume: 18,423,248
Technical Sentiment Signal: Sell
Current Market Cap: $449.8K
For an in-depth examination of RDGT stock, go to TipRanks’ Overview page.